Impaired kidney function: supporting the safe use of medicines for patients
Intended for healthcare professionals
Evidence and practice    

Impaired kidney function: supporting the safe use of medicines for patients

Kathrine Parker Highly specialist renal pharmacist, Manchester University NHS Foundation Trust, and honorary senior clinical lecturer, University of Manchester, Manchester, England
Janette Chu Lead pharmacist – renal services, Manchester University NHS Foundation Trust, Manchester, England

Why you should read this article:
  • To enhance your knowledge of the effects of kidney function impairment on pharmacokinetics

  • To recognise the factors to consider when prescribing and administering medicines to patients with acute kidney injury or chronic kidney disease

  • To understand the nurse’s role in ensuring safe medicines use for patients with impaired kidney function

Due to the increasing incidence of acute kidney injury (AKI) and chronic kidney disease (CKD), nurses in most healthcare settings are likely to care for patients with some degree of impaired kidney function. Impaired kidney function can adversely affect the way the body excretes, absorbs, distributes and metabolises medicines (pharmacokinetics), potentially resulting in a wide range of drug-related complications. This article provides an overview of the effects of impaired kidney function on pharmacokinetics and the importance of accurate drug dose adjustments for patients with related conditions. It also discusses various aspects of medicines use in patients with AKI, the pharmacological management of patients with CKD and the use of immunosuppressive therapy in patients who have had a kidney transplant. The authors consider the role of the nurse in ensuring safe medicines use for patients with impaired kidney function throughout the article.

Nursing Standard. doi: 10.7748/ns.2024.e12075

Peer review

This article has been subject to external double-blind peer review and checked for plagiarism using automated software

@KattyParker84

Correspondence

Kathrine.Parker@mft.nhs.uk

Conflict of interest

Kathrine Parker has received speaker fees and an honorarium from Bayer, AstraZeneca, Vifor Ltd and Astellas. None of the companies were involved in the writing of this article

Parker K, Chu J (2024) Impaired kidney function: supporting the safe use of medicines for patients. Nursing Standard. doi: 10.7748/ns.2024.e12075

Published online: 22 April 2024

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more